The Korea Food and Drug Administration (KFDA) on April 9 recalled 1,122 medicine products from 120 drug manufacturers that have been contaminated with asbestos. The regulatory measures are as follows: 

The Korea Consumer Agency (President Myung-hee Park, www.kca.go.kr) asks consumers to be more cautious when taking medicines or keeping them at home. Consumers who are taking the concerned medicines or keeping them at home are asked to act positively in concert with the Government’s recall measure. 

Consumers who need more information on side-effect, exchange, or return of the medicine that are suspected of asbestos-containing talc are advised to call to the KFDA or visit the website as below.

※ Main number for the KFDA: 1577-1255

※ For information on asbestos-contaminated drugs, visit the KFDA web site of http://www.foodnara.go.kr/kfda/asbestos/main/main.html